NKTR short setup

NASDAQ:NKTR   Nektar Therapeutics
NKTR’s innovation outlook is trending down based on a current score of 60 out of 99, outperforming sector average. Insiders sentiment is negative. Over the past 4 quarters NKTR beat earnings estimates 4 times.
For more analysis and articles visit our website.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.